Global Orphan Drugs Market Research Report 2022
Summary
Market Analysis and Insights: Global Orphan Drugs Market
The global Orphan Drugs market size is projected to reach US$ 269.15 Billion by 2028, from US$ 139.17 million in 2021, at a CAGR of 9.86% during 2022-2028.
Fully considering the economic change by this health crisis, Oncology accounting for 63.30% of the Orphan Drugs global market in 2021, is projected to value US$ 172.77 Billion by 2028, growing at a revised 10.05% CAGR in the post-COVID-19 period. While Adult segment is altered to an 10.01% CAGR throughout this forecast period.
China Orphan Drugs market size is valued at US$ 19.06 Billion in 2021, while the North America and Europe Orphan Drugs are US$ 57.07 Billion and US$ 26.14 Billion, severally. The proportion of the North America is 41.01% in 2021, while China and Europe are 13.70% and 18.80% respectively, and it is predicted that China proportion will reach 14.14% in 2028, trailing a CAGR of 10.28% through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR 9.89%, 9.10%, and 9.56% respectively for the next 6-year period. As for the Europe Orphan Drugs landscape, Germany is projected to reach US$ 12.17 Billion by 2028 trailing a CAGR of 10.11% over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Orphan Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Orphan Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Orphan Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Orphan Drugs market.
Global Orphan Drugs Scope and Market Size
Orphan Drugs market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Orphan Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
Bristol-Myers Squibb
Roche
Novartis
Johnson & Johnson
Pfizer
Amgen
Sanofi
AstraZeneca
Takeda
Vertex Pharmaceuticals
AbbVie
Biogen
Eli Lilly
Segment by Type
Oncology
Pulmonary
Neurology
Hematology
Endocrinology
Cardio-vascular
Metabolic Disorders
Other
Segment by Application
Baby & Child
Teenager
Adult
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
South America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook